In contrast, treatment with digitoxin plus MEK inhibitor significantly reduced NHE activity in both melanomas compared with control mice and mice treated with digitoxin or MEK inhibitor alone (Fig. 4d). The gene discussed is SLC9C1; the disease is melanoma.